Nanosonics Limited is a medical instruments & supplies business based in Australia. Nanosonics shares (NAN) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $5.91 – an increase of 0.51% over the previous week. Nanosonics has a trailing 12-month revenue of around $100.1 million.
How to buy shares in Nanosonics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Nanosonics. Find the share by name or ticker symbol: NAN. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Nanosonics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $5.91, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Nanosonics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
How has coronavirus impacted Nanosonics's share price?
Since the stock market crash in March caused by coronavirus, Nanosonics's share price has had significant negative movement.
Its last market close was $5.91, which is 18.03% down on its pre-crash value of $7.21 and 47.38% up on the lowest point reached during the March crash when the shares fell as low as $4.01.
If you had bought $1,000 worth of Nanosonics shares at the start of February 2020, those shares would have been worth $637.98 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $862.80.
Nanosonics share priceUse our graph to track the performance of NAN stocks over time.
Nanosonics shares at a glance
|Latest market close||AUDA$5.91|
|52-week range||AUDA$4.01 - AUDA$7.73|
|50-day moving average||AUDA$6.1971|
|200-day moving average||AUDA$6.3684|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$0.033|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Nanosonics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Nanosonics price performance over time
|1 week (2020-09-10)||0.85%|
|1 month (2020-08-20)||-9.08%|
|3 months (2020-06-19)||-12.31%|
|6 months (2020-03-20)||27.37%|
|1 year (2019-09-20)||-8.51%|
|2 years (2018-09-20)||92.51%|
|3 years (2017-09-20)||126.44%|
|5 years (2015-09-18)||337.78%|
Is Nanosonics under- or over-valued?
Valuing Nanosonics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nanosonics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nanosonics's P/E ratio
Nanosonics's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 177x. In other words, Nanosonics shares trade at around 177x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Nanosonics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $15 million (£0.0 million).
The EBITDA is a measure of a Nanosonics's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$100.1 million|
|Operating margin TTM||12.33%|
|Gross profit TTM||$75.5 million|
|Return on assets TTM||5.58%|
|Return on equity TTM||8.65%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
Nanosonics share dividends
We're not expecting Nanosonics to pay a dividend over the next 12 months.
Nanosonics share price volatility
Over the last 12 months, Nanosonics's shares have ranged in value from as little as $4.01 up to $7.73. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Nanosonics's is 1.0825. This would suggest that Nanosonics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nanosonics Limited, together with its subsidiaries, engages in the research, development, and commercialization of infection control and decontamination products and related technologies. The company manufactures and distributes the trophon ultrasound probe disinfector, and its associated consumables and accessories for reducing cross-contamination between patients and the spread of healthcare acquired infections. It also provides trophon2, an ultrasound probe high level disinfection device; and trophon EPR, a device designed to disinfect intracavity and surface ultrasound probes. In addition, the company offers trophon EPR and trophon2 consumables and accessories, including NanoNebulant, a proprietary disinfectant liquid; trophon chemical indicators; trophon AcuTrace operator cards, medical instrument tags, printers, printer USB cables, printer label rolls, and logbooks; trophon wall mounts, printer wall mounts, carts, and printer cart mounts; trophon companion drying wipes and companion wipes wall mounts; clean ultrasound probe covers; and trophon AcuTrace PLUS activation cards. It operates in North America, Europe, the Middle East, and the Asia Pacific. The company was incorporated in 2000 and is headquartered in Lane Cove, Australia.
Frequently asked questions
Ask an Expert